{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "05/21/2026",
      "update_type": "New",
      "initial_posting_date": "05/21/2026",
      "package_ndc": "67457-957-99",
      "generic_name": "Iron Sucrose Injection",
      "contact_info": "800-796-9526",
      "related_info": "A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK.",
      "openfda": {
        "application_number": [
          "ANDA212559"
        ],
        "brand_name": [
          "IRON SUCROSE"
        ],
        "generic_name": [
          "IRON SUCROSE"
        ],
        "manufacturer_name": [
          "Mylan Institutional LLC"
        ],
        "product_ndc": [
          "67457-957",
          "67457-638",
          "67457-639"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "IRON SUCROSE"
        ],
        "rxcui": [
          "1741261",
          "1741267",
          "1741270"
        ],
        "spl_id": [
          "6ed21b25-9fbf-4a33-99e5-da98a4aa72bd"
        ],
        "spl_set_id": [
          "3f109bdb-a412-43b2-84c7-9dad05e85a71"
        ],
        "package_ndc": [
          "67457-957-99",
          "67457-638-10",
          "67457-638-25",
          "67457-639-10"
        ],
        "nui": [
          "M0011718",
          "N0000177913"
        ],
        "pharm_class_cs": [
          "Iron [CS]"
        ],
        "pharm_class_epc": [
          "Parenteral Iron Replacement [EPC]"
        ],
        "unii": [
          "FZ7NYF5N8L"
        ]
      },
      "update_date": "05/21/2026",
      "therapeutic_category": [
        "Hematology"
      ],
      "dosage_form": "Injection",
      "presentation": "Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)",
      "company_name": "Mylan Institutional, a Viatris Company",
      "status": "To Be Discontinued"
    }
  ]
}